These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 35315538

  • 1. Clinicohistological and immunopathological features of patients with cutaneous lupus erythematosus at tertiary dermatology centre in Malaysia.
    Teh YC, Loo CH, Mohd Ali N, Lim AL, Tan WC.
    Clin Exp Dermatol; 2022 Aug; 47(8):1490-1501. PubMed ID: 35315538
    [Abstract] [Full Text] [Related]

  • 2. The study of Cutaneous Lupus Erythematosus Disease Area and Severity Index in Indian patients with systemic lupus erythematosus.
    Salphale P, Danda D, Chandrashekar L, Peter D, Jayaseeli N, George R.
    Lupus; 2011 Dec; 20(14):1510-7. PubMed ID: 21997966
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Natural history of disease activity and damage in patients with cutaneous lupus erythematosus.
    Ker KJ, Teske NM, Feng R, Chong BF, Werth VP.
    J Am Acad Dermatol; 2018 Dec; 79(6):1053-1060.e3. PubMed ID: 29969701
    [Abstract] [Full Text] [Related]

  • 5. Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures.
    Jolly M, Kazmi N, Mikolaitis RA, Sequeira W, Block JA.
    J Am Acad Dermatol; 2013 Apr; 68(4):618-623. PubMed ID: 23107310
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical characteristics of itch in cutaneous lupus erythematosus: A prospective, multicenter, multinational, cross-sectional study.
    Samotij D, Szczęch J, Antiga E, Bonciani D, Caproni M, Chasset F, Dańczak-Pazdrowska A, Furukawa F, Hasegawa M, Hashizume H, Ikeda T, Islam A, Kim HJ, Lesiak A, Misery L, Mowla MR, Polańska A, Szepietowski JC, Tsuruta D, Verdelli A, Werth VP, Reich A.
    Lupus; 2021 Aug; 30(9):1385-1393. PubMed ID: 34000879
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Robust measurement of clinical improvement in patients with cutaneous lupus erythematosus.
    Nanes BA, Zhu JL, Chong BF.
    Lupus Sci Med; 2020 Aug; 7(1):e000364. PubMed ID: 32095249
    [Abstract] [Full Text] [Related]

  • 10. Ten-year retrospective clinicohistological study of cutaneous lupus erythematosus in Korea.
    Oh EH, Kim EJ, Ro YS, Ko JY.
    J Dermatol; 2018 Apr; 45(4):436-443. PubMed ID: 29423919
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosus.
    Bonilla-Martinez ZL, Albrecht J, Troxel AB, Taylor L, Okawa J, Dulay S, Werth VP.
    Arch Dermatol; 2008 Feb; 144(2):173-80. PubMed ID: 18283174
    [Abstract] [Full Text] [Related]

  • 13. Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients.
    Chanprapaph K, Tubtieng I, Pratumchat N, Thadanipon K, Rattanakaemakorn P, Suchonwanit P.
    Lupus; 2021 Apr; 30(5):785-794. PubMed ID: 33554715
    [Abstract] [Full Text] [Related]

  • 14. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score.
    Braunstein I, Klein R, Okawa J, Werth VP.
    Br J Dermatol; 2012 May; 166(5):971-5. PubMed ID: 22242767
    [Abstract] [Full Text] [Related]

  • 15. ARA and EADV criteria for classification of systemic lupus erythematosus in patients with cutaneous lupus erythematosus.
    Parodi A, Rebora A.
    Dermatology; 1997 May; 194(3):217-20. PubMed ID: 9187836
    [Abstract] [Full Text] [Related]

  • 16. Cutaneous Toll-like Receptor 9 Pre-Defines Hydroxychloroquine Dosage in Patients with Both Discoid and Subacute Lupus Erythematosus.
    Englert KA, Dyduch G, Kłosowicz A, Spałkowska M, Jaworek AK, Migacz-Gruszka K, Jarosz-Chudek A, Mercuri SR, Szpor J, Mazzoccoli G, Damiani G, Wojas-Pelc A.
    Medicina (Kaunas); 2023 Nov 17; 59(11):. PubMed ID: 38004071
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of autoantibodies and cytokines related to cutaneous lupus erythematosus.
    Hu FQ, Zhang YP, Yin J, Tang ZQ, Han YF, Shi ZR, Tan GZ, Wang L.
    Lupus; 2021 Feb 17; 30(2):315-319. PubMed ID: 33086919
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.